Cargando…

Profiling hymenopteran venom toxins: Protein families, structural landscape, biological activities, and pharmacological benefits

Hymenopterans are an untapped source of venom secretions. Their recent proteo-transcriptomic studies have revealed an extraordinary pool of toxins that participate in various biological processes, including pain, paralysis, allergic reactions, and antimicrobial activities. Comprehensive and clade-sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Guido-Patiño, Juan Carlos, Plisson, Fabien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971319/
https://www.ncbi.nlm.nih.gov/pubmed/35372826
http://dx.doi.org/10.1016/j.toxcx.2022.100119
_version_ 1784679607262248960
author Guido-Patiño, Juan Carlos
Plisson, Fabien
author_facet Guido-Patiño, Juan Carlos
Plisson, Fabien
author_sort Guido-Patiño, Juan Carlos
collection PubMed
description Hymenopterans are an untapped source of venom secretions. Their recent proteo-transcriptomic studies have revealed an extraordinary pool of toxins that participate in various biological processes, including pain, paralysis, allergic reactions, and antimicrobial activities. Comprehensive and clade-specific campaigns to collect hymenopteran venoms are therefore needed. We consider that data-driven bioprospecting may help prioritise sampling and alleviate associated costs. This work established the current protein landscape from hymenopteran venoms to evaluate possible sample bias by studying their origins, sequence diversity, known structures, and biological functions. We collected all 282 reported hymenopteran toxins (peptides and proteins) from the UniProt database that we clustered into 21 protein families from the three studied clades - wasps, bees, and ants. We identified 119 biological targets of hymenopteran toxins ranging from pathogen membranes to eukaryotic proteases, ion channels and protein receptors. Our systematic study further extended to hymenopteran toxins' therapeutic and biotechnological values, where we revealed promising applications in crop pests, human infections, autoimmune diseases, and neurodegenerative disorders.
format Online
Article
Text
id pubmed-8971319
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89713192022-04-02 Profiling hymenopteran venom toxins: Protein families, structural landscape, biological activities, and pharmacological benefits Guido-Patiño, Juan Carlos Plisson, Fabien Toxicon X Articles from Special Issue on EUVEN2021: Venoms in Europe and beyond; Edited by Dr Gregor Anderluh, Dr. Figen Caliskan, Dr. Maria Vittoria Modica and Dr. Manuel Jimenez Tenorio Hymenopterans are an untapped source of venom secretions. Their recent proteo-transcriptomic studies have revealed an extraordinary pool of toxins that participate in various biological processes, including pain, paralysis, allergic reactions, and antimicrobial activities. Comprehensive and clade-specific campaigns to collect hymenopteran venoms are therefore needed. We consider that data-driven bioprospecting may help prioritise sampling and alleviate associated costs. This work established the current protein landscape from hymenopteran venoms to evaluate possible sample bias by studying their origins, sequence diversity, known structures, and biological functions. We collected all 282 reported hymenopteran toxins (peptides and proteins) from the UniProt database that we clustered into 21 protein families from the three studied clades - wasps, bees, and ants. We identified 119 biological targets of hymenopteran toxins ranging from pathogen membranes to eukaryotic proteases, ion channels and protein receptors. Our systematic study further extended to hymenopteran toxins' therapeutic and biotechnological values, where we revealed promising applications in crop pests, human infections, autoimmune diseases, and neurodegenerative disorders. Elsevier 2022-03-29 /pmc/articles/PMC8971319/ /pubmed/35372826 http://dx.doi.org/10.1016/j.toxcx.2022.100119 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles from Special Issue on EUVEN2021: Venoms in Europe and beyond; Edited by Dr Gregor Anderluh, Dr. Figen Caliskan, Dr. Maria Vittoria Modica and Dr. Manuel Jimenez Tenorio
Guido-Patiño, Juan Carlos
Plisson, Fabien
Profiling hymenopteran venom toxins: Protein families, structural landscape, biological activities, and pharmacological benefits
title Profiling hymenopteran venom toxins: Protein families, structural landscape, biological activities, and pharmacological benefits
title_full Profiling hymenopteran venom toxins: Protein families, structural landscape, biological activities, and pharmacological benefits
title_fullStr Profiling hymenopteran venom toxins: Protein families, structural landscape, biological activities, and pharmacological benefits
title_full_unstemmed Profiling hymenopteran venom toxins: Protein families, structural landscape, biological activities, and pharmacological benefits
title_short Profiling hymenopteran venom toxins: Protein families, structural landscape, biological activities, and pharmacological benefits
title_sort profiling hymenopteran venom toxins: protein families, structural landscape, biological activities, and pharmacological benefits
topic Articles from Special Issue on EUVEN2021: Venoms in Europe and beyond; Edited by Dr Gregor Anderluh, Dr. Figen Caliskan, Dr. Maria Vittoria Modica and Dr. Manuel Jimenez Tenorio
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971319/
https://www.ncbi.nlm.nih.gov/pubmed/35372826
http://dx.doi.org/10.1016/j.toxcx.2022.100119
work_keys_str_mv AT guidopatinojuancarlos profilinghymenopteranvenomtoxinsproteinfamiliesstructurallandscapebiologicalactivitiesandpharmacologicalbenefits
AT plissonfabien profilinghymenopteranvenomtoxinsproteinfamiliesstructurallandscapebiologicalactivitiesandpharmacologicalbenefits